UNIDADE LOCAL DE SAUDE DE COIMBRA EPE

Their core work

ULS Coimbra is a major public hospital system in Coimbra, Portugal — one of the country's leading university hospital centers. They contribute clinical expertise, patient cohorts, and real-world healthcare data to European research projects spanning infectious disease preparedness, neuroscience, ophthalmology, and critical care. Their role in H2020 projects reflects a hospital that actively bridges clinical practice with translational research, particularly in testing new medical devices, digital health tools, and therapeutic approaches within actual hospital settings.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2018), ULS Coimbra focused on broad clinical research — infectious disease preparedness (ZIKAction), glucocorticoid treatment trials (GLORIA), and protein analysis training networks (MASSTRPLAN). From 2019 onward, their portfolio shifted decisively toward technology-integrated medicine: AI-powered ICU monitoring (ENVISION), telerehabilitation platforms (ROSIA), virtual surgical planning with neural networks (VEMoS), and safer medical device innovation (SAFE-Infusion). This evolution shows a hospital system that moved from being a clinical data provider to becoming an active partner in developing and validating digital health and medtech solutions.

ULS Coimbra is rapidly building capacity in AI-assisted clinical decision-making and remote care delivery, positioning itself as a go-to clinical validation partner for health technology developers.

How they like to work

ULS Coimbra operates exclusively as a participant or third party — they have never coordinated an H2020 project. This is typical of large hospital systems that contribute clinical infrastructure, patient access, and domain expertise rather than leading project management. With 117 unique partners across 24 countries, they connect broadly and do not cluster around a few repeat collaborators, making them an accessible partner for new consortia seeking a Portuguese clinical site.

Extensive European network with 117 unique consortium partners spanning 24 countries. Their reach reflects participation in large multi-site clinical and innovation consortia rather than concentrated bilateral partnerships.

What sets them apart

ULS Coimbra offers something uncommon: a large Portuguese public hospital system with demonstrated experience validating both digital health tools and physical medical devices within real clinical workflows. Their portfolio covers ICU monitoring, telerehabilitation, IV safety devices, and surgical simulation — giving them practical know-how across the hospital from emergency room to outpatient care. For consortium builders, they bring a credible clinical validation site in a Southern European healthcare context, with a track record of working in large international teams.

Highlights from their portfolio

• VEMoS
  Highest single-project funding (EUR 402K) — combined neural networks with ophthalmology for personalised refractive surgery simulation, an unusual intersection of AI and eye care.
• ENVISION
  Deployed AI-driven real-time surveillance and predictive modelling in COVID-19 ICU settings, demonstrating the hospital's capacity to adopt and test digital tools under crisis conditions.
• SAFE-Infusion
  Addressed a critical patient safety gap in IV therapy with practical device innovations (break-away connectors, bubble aspirators), showing engagement with medtech beyond software.